Yi-Wei Tang, Ph.D., obtained his medical training from Fudan University Shanghai School of Medicine and a Ph.D. in microbiology and immunology from Vanderbilt University. Tang is currently the Academic Dean of the College of Public Health at Chongqing Medical University and a member of the Consensus Committee on Molecular Methods of the Clinical and Laboratory Standards Institute in the U.S.

He was the China Chief Medical Officer of Danaher Corporation/Cepheid in Shanghai, a lecturer and clinical fellow at the Mayo Clinic, a professor at the Vanderbilt University School of Medicine, the Chief of the Clinical Microbiology Service at the Memorial Sloan-Kettering Cancer Center, a professor of pathology and laboratory medicine at the Weill Medical College of Cornell University, the Chairman of the Overseas Chinese Society for Microbiology, a member of the Medical Devices Advisory Committee of the U.S. Food and Drug Administration and a curator of the American Society for Microbiology COVID-19 Research Registry.

Tang ranks among the top of the scientific field in clinical and molecular microbiology, as evidenced by his election as an editor for the Journal of Clinical Microbiology, an associate editor for the Journal of Molecular Diagnostics, an associate editor for the Emerging Microbes and Infection and a fellow of the American Academy for Microbiology and of the Infectious Disease Society of America. Tang has been recognized for his extraordinary expertise in molecular microbiology diagnosis and monitoring with over 250 peer-reviewed articles and over 150 book chapters in this field during the past 30 years.